Contractor
PFIZER INC
- UEI
- MHBQULRMEEJ5
- Parent UEI
- MHBQULRMEEJ5
- Resolved by
- uei
- Confidence
- 1.000
Active from Dec 22, 2020 to Oct 5, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75D30121D11355 2021 VACCINES FOR ADULTS | Department of Health and Human Services | — | Jun 25, 2021 | — |
| 36F79724D0130 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Jun 5, 2024 | — |
| 36E79725D0032 NEW AWARD FOR RITUXIMAB WITH PFIZER INC. BASE YEAR ORDERING PERIOD IS SEPTEMBER 15, 2025 TO SEPTEMBER 14, 2026 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Apr 29, 2025 | — |
| 75D30126D21004 FY 26-27 ADULT COVID VACCINES EO 14398 | Department of Health and Human Services | — | May 29, 2026 | — |
| 75D30126D21001 FY26-27 PEDIATRIC COVID VACCINES EO 14398 | Department of Health and Human Services | — | May 29, 2026 | — |
| 36E79725D0030 NEW AWARD FOR BEVACIZUMAB INJECTIONS WITH PFIZER, INC. ORDERING PERIOD IS AUGUST 13, 2025 TO AUGUST 12, 2026 WITH FOUR ONE-YEAR OPTIONS | Department of Veterans Affairs | — | Apr 11, 2025 | — |
| 75D30126D20938 VACCINES FOR ADULTS EO 14398 | Department of Health and Human Services | — | Jun 8, 2026 | — |
| 75D30126D20730 VACCINES FOR CHILDREN | Department of Health and Human Services | — | Mar 27, 2026 | — |
| 75D30125D00194 END OF PWS | Department of Health and Human Services | — | Jun 29, 2026 | — |
| 75D30125D20474 ADULT COVID VACCINES | Department of Health and Human Services | — | Apr 30, 2026 | — |
| 75D30125D20482 ADULT VACCINES | Department of Health and Human Services | — | Jun 16, 2025 | — |
| 75D30122F00001 PFIZER VACCINES STORAGE AND ROTATION CONTRACT | Department of Health and Human Services | NY | Jul 25, 2022 | $2,151,168 |
| 75D30122D14203 PFIZER VACCINES STORAGE AND ROTATION CONTRACT | Department of Health and Human Services | — | Jul 25, 2022 | — |
| 75A50326F63004 STERILE WATER FOR INJECTION, 20ML | Department of Health and Human Services | NY | May 15, 2026 | $542,605 |
| HHSO100201500029C THE PURPOSE OF MODIFICATION P00014 IS TO DE-OBLIGATE CANCELING FUNDS | Department of Health and Human Services | — | May 12, 2026 | $93,359,027 |
| SPE2D326F109N 4571786066!ATROPINE 1 MG/10 ML SYRINGE 10ML | Department of Defense | NY | May 11, 2026 | $77 |
| SPE2D326F109M 4571785312!METOPROLOL TART 5 MG/5 ML VIAL 5ML | Department of Defense | NY | May 11, 2026 | $6 |
| SPE2D326F105P 4571769652!LORAZEPAM 2 MG/ML CARPUJECTML | Department of Defense | NY | May 8, 2026 | $135 |
| SPE2D326F108A 4571786068!LIDOCAINE HCL 1% VIAL 50ML | Department of Defense | NY | May 8, 2026 | $965 |
| SPE2D326F107U 4571786064!ONDANSETRON HCL 4 MG/2 ML VIAL 2ML | Department of Defense | NY | May 8, 2026 | $32 |
| SPE2D326F107H 4571786060!CYKLOKAPRON 1,000 MG/10 ML VL 10ML | Department of Defense | NY | May 8, 2026 | $225 |
| SPE2D326F106F 4571771060!SOLU-MEDROL 125 MG VIALS | Department of Defense | NY | May 8, 2026 | $943 |
| SPE2D326F105U 4571771056!CEFTRIAXONE 1 GM VIALS | Department of Defense | NY | May 8, 2026 | $69 |
| SPE2D326F105N 4571768582!ACETYLCYSTEINE 20% VIAL 30ML | Department of Defense | NY | May 8, 2026 | $60 |
| SPE2D326F105E 4571769649!NALOXONE 0.4 MG/ML VIALML | Department of Defense | NY | May 8, 2026 | $151 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier MHBQULRMEEJ5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.